Identification of factors limiting patient recruitment into phase I trials: A study from the Royal Marsden Hospital

European Journal of Cancer

Volumn 44, Issue 7, 2008, Pages 978-982

  Karavasilis, Vasilios ^a   Digue, Laurence ^a   Arkenau, Tobias ^a   Eaton, David ^a   Stapleton, Sarah ^a   de Bono, Johann ^a   Judson, Ian ^a   Kaye, Stan ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Limiting factors; Phase I trials; Recruitment

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RESEARCH; FEMALE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CLINICAL TRIALS, PHASE I AS TOPIC; FEMALE; HOSPITALIZATION; HUMANS; LONDON; MALE; MEDICAL AUDIT; MIDDLE AGED; NEOPLASMS; PATIENT SELECTION; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; TIME FACTORS; WAITING LISTS;

EID: 42649097570     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2008.02.040     Document Type: Article

References (10)

1. Camidge D.R., Eckhardt S.G., and Gore L. Dynamic and modern: bringing the ethics of phase I trials up to date. J Clin Oncol 24 (2006) 5178-5179
2. Daugherty C.K. Ethical issues in phase I clinical trials. Clin Adv Hematol Oncol 2 (2004) 358-360
3. Downward J. Cancer biology: signatures guide drug choice. Nature 439 (2006) 274-275
4. Steeg P.S. Cancer biology: emissaries set up new sites. Nature 438 (2005) 750-751
5. Daugherty C.K. Ethical issues in the development of new agents. Invest New Drugs 17 (1999) 145-153
6. Horstmann E., McCabe M.S., Grochow L., et al. Risks and benefits of phase 1 oncology trials, 1991 through 2002. New Engl J Med 352 (2005) 895-904
7. Ho J., Pond G.R., Newman C., et al. Barriers in phase I cancer clinical trials referrals and enrollment: five-year experience at the Princess Margaret Hospital. BMC Cancer 6 (2006) 263
8. Corrie P., Shaw J., and Harris R. Rate limiting factors in recruitment of patients to clinical trials in cancer research: descriptive study. BMJ 327 (2003) 320-321
9. Lara Jr. P.N., Higdon R., Lim N., et al. Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment. J Clin Oncol 19 (2001) 1728-1733
10. Kaitin K. Obstacles and opportunities in new drug development. Mol Ther 83 (2008) 210-212